Yantai Dongcheng Biochemicals Co.,Ltd.



Quote for Yantai Dongcheng Biochemicals Co.,Ltd.

Last Trade:
-
Change:
--
Symbol/Code:
002675
Status:
-
Stock Type:
A Share
Market Cap:
-
Open:
-
Prev Close:
-
Bid:
-
Ask:
-
Volume(*100):
-
Amount:
-
Limit Up:
-
Limit Down:
-
Day's Range:
-
P/E(ttm):
-
P/B ratio
-
Update:-
Currency in CNY Time=UTC+8002675 quote

Summary for Yantai Dongcheng Biochemicals Co.,Ltd.

Yantai Dongcheng Biochemicals Co.,Ltd. Is a comprehensive company, which produces not only pharmaceutical ingredients, but also preparations. Its business scope is production, processing and sales of heparin sodium, chondroitin sulphate and their series products. On the basis of production of biochemicals and pharmaceutical ingredients, last year this company has successfully purchased Yantai Beifang Pharmaceutical Co.,Ltd., which is one preparations factory that completely complies with GMP and owns two production lines-small volume parenteral solution and Lyophilized powder for injection production lines.Yantai Dongcheng Biohcemicals Co.,Ltd. Broke ground in March, 1999, covering an area of 156382 square meters, its construction area is 4101 square meters. This company has started production in Feburary, 2000 and has obtained GMP certificate issued by State Drug Administration of China during July in the same year. This company has also been accredited as HI-Tech enterprise by Science and Technology Department of Shandong Province in December, 2000. This company haspassed ISO9002 certification audited by DNV in April, 2001, so this company has become the only one that is wholly GMP and ISO9002 approved in biochemical and pharmaceutical ingredients line in China.At present, the products of this company are mainly exported to South America, North America, Europe, Southeast Asian countries etc. Total sales amount in 2001 is 12 million U.S.Dollars, and estimated sales amount in 2003 would be 15 million U.S.Dollars.Yantai Dongcheng Biochemicals Co.,Ltd. Has set up a strict quality assurance system, advanced production equipments, facilities and production process are completely comply with GMP standards, imported analytical instruments and specialized technical personnel guarantee the accuracy of the test results.

Profile for Yantai Dongcheng Biochemicals Co.,Ltd.

Full Name:Yantai Dongcheng Biochemicals Co.,Ltd.
Full Name in Chinese:烟台东诚生化股份有限公司 Short Name in Chinese:东诚生化
Symbol/Stock Code:
002675
Listed in:
Shenzhen Stock Exchange
Issued Capital
-
Negotiable Capital:
-
Chairman:
You Shouyi
Secretary of the Board:
Song Tianfeng
Phone:
+86-535-6371119
Fax:
+86-535-6371119
Official Website:www.dcb-group.com
E-mail:stf_1@163.com
Address:No. 7 Changbaishan Road, Yantai Dev. Zone, Shandong,264006
IPO Subscription Date:
2012-05-15
Listing Date:
2012-05-25
IPO Issued Capital:
27000000
IPO Price:
26
IPO fees:
62637100 CNY
Money Raised by IPO:
702000000 CNY
IPO Par Value:
1.00 CNY
Net Money Raised:
639362900 CNY
Open(Listing day):
- CNY
Close(Listing day):
- CNY
Diluted P/E ratio after IPO:
22.8100
Turnover rate(listing day):
-%

Financials for Yantai Dongcheng Biochemicals Co.,Ltd.

UPDATE:2012-10-21 Annual Report Abstract:(All Currency In CNY)

Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Net Profit(after tax)(Million)
88.6441
127.9345
50.6391
31.9885
Net Profit Growth(%)
-8.63
152.63
58.30
112.33
Return On Equity(ROE)(%)
8.87
42.05
26.53
22.81
Debt ratio(%)
2.62
32.53
46.80
47.39
Net Operating Cash Flow/Net Profit(%)
-17.18
108.51
112.59
-83.16

Per Share Financial Data:(All Currency In CNY)

Per Share Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Earnings Per Share(EPS)
0.9500
1.5800
0.6300
0.4700
Diluted Earnings Per Share
0.0000
1.5200
0.6200
0.4500
Net Asset Value Per Share (NAVPS)
9.2500
3.7600
2.3600
1.7300
Additional Paid-In Capital Per Share
5.8258
0.2077
0.5410
0.6151
Retained Earnings Per Share
2.1021
2.1184
0.9567
0.4234
Net Cash Flow From Operatings Activities Per Share
-0.1400
1.7100
0.7000
-0.3300
Net Cash Flow Per Share
4.5099
0.7703
0.6757
0.0314

Balance Sheet:(All Currency In CNY)

Assets And Liabilities/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Total Assets(Million)
1026.0458
451.2376
359.1953
266.9628
Total Liabilities(Million)
26.9066
146.8192
168.1358
126.5309
Current Liabilities(Million)
26.9066
146.8192
168.1358
96.5309
Long Term Liabilities(Million)
-
-
-
-
Cash And Cash Equivalents(Million)
612.2593
125.1693
62.8041
9.8042
Accounts Receivables(Million)
82.0662
56.7302
63.8895
52.1206
Deposit Received(Million)
2.4349
2.4462
1.1844
1.8297
Other Receivables(Million)
3.7362
7.9638
1.9687
1.9588
Bad Debt Reserve(Million)
-
-
-
-
Shareholder's Equity/Owner's Equity(Million)
999.0233
304.2211
190.8666
140.2274
Debt ratio(%)
2.62
32.53
46.80
47.39
Equity Ratio(%)
97.3600
67.4100
53.1300
52.5200
Current Ratio
33.9700
2.3972
1.6047
1.9265
Quick Ratio
27.2807
1.4143
0.8256
0.7783

Cash Flow Statement:(All Currency In CNY)

Cash Flow/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Cash From Selling Commodities(Million)
415.3326
859.3715
656.019
360.8606
Net Cash Flow From Operatings Activities(Million)
-15.2254
138.8262
57.0166
-26.602
Net Cash Flow From Operatings Activities Change(%)
-198.78
143.48
-314.33
-164.00
Net Cash Flow(Million)
487.0732
62.3935
54.7333
2.5403
Cash From Selling Commodities/Prime Revenue(%)
94.33
100.21
98.85
95.86
Net Cash Flow/Net Profit(%)
549.47
48.77
108.09
7.94
Cash Flow From Investing Activities(Million)
-18.742
-17.724
-16.0553
-44.8051
Cash Flow From Financing Activities(Million)
520.6562
-59.4005
13.8762
73.9405

Income Statement:(All Currency In CNY)

Income Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Prime Operating Revenue(Million)
440.3001
857.573
663.6284
376.4585
Prime Operating Profit(Million)
-
-
-
-
Operating Costs(Million)
10.3734
11.0354
6.8032
6.2894
Administrative Costs(Million)
26.3298
27.6991
19.3858
15.4665
Financing Costs(Million)
-4.1441
13.9039
11.2652
5.8617
Above Three Costs Change(%)
-20.28
40.54
35.62
-7.71
Operating Profit(Million)
102.8924
144.8112
59.2991
36.4679
Income From Investment(Million)
-0.0525
-0.0436
-0.0239
-
Government Subsidies(Million)
-
-
-
-
Net Non-Operating Income And Expense(Million)
2.354
6.0135
0.7831
1.898
Total Profit(Million)
105.2464
150.8248
60.0823
38.3659
Corporate Income Tax(Million)
16.6837
22.8859
9.4546
6.0061
Net Profit(Million)
88.6441
127.9345
50.6391
31.9885
Gross Profit Ratio(%)
31.53
23.48
14.76
17.08
Operating Margin(%)
23.36
16.88
8.93
9.68
Return On Equity(ROE)(%)
8.87
42.05
26.53
22.81

Announcements for Yantai Dongcheng Biochemicals Co.,Ltd.

Date: 2012-08-16
Title: EGM RESOLUTION
The Company held its 2nd Extraordinary General Meeting of 2012 on 15 August 2012, during which the following proposal(s) was/were approved:
1. Change of business scope and amendments to the company's articles of association
Date: 2012-07-06
Title: EGM-SPOT
The Company will hold the 2nd Extraordinary General Meeting of 2012 at 14:00 on 15 August 2012.

Meeting agenda:
1. Change of business scope and amendments to the company's articles of association

Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 08 August 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: 09 August 2012
Date: 2012-07-06
Title: EGM RESOLUTION
The Company held its 1st Extraordinary General Meeting of 2012 on 05 July 2012, during which the following proposal(s) was/were approved:
1. Investment in the construction of a project
2. Amendments to the Company's articles of association applicable after listed(draft)
3. By-election of Sun Hongtao as supervisor
4. Adjustment to the remuneration for independent directors.
Date: 2012-06-20
Title: EGM-SPOT
The Company will hold the 1st Extraordinary General Meeting of 2012 at 09:00 on 05 July 2012.

Meeting agenda:
1. Investment in the construction of a project
2. Amendments to the Company's articles of association applicable after listed(draft)
3. By-election of Sun Hongtao as supervisor
4. Adjustment to the remuneration for independent directors

Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 29 June 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: 02 July 2012
Date: 2012-05-24
Title: IPO SHARE LISTING
The Company issued a total of 27 million shares (code:002675) in its initial public offering. Of the shares,27 million shares will be listed on the Shenzhen Stock Exchange on 25 May 2012 while the remainder will become tradable three months later.
Date: 2012-05-14
Title: IPO-ONLINE SUBSCRIPTION
Yantai Dongcheng Biochemicals Co.,Ltd. has been approved by the China Securities Regulatory Commission (the CSRC) to issue 27.000000 million A-shares in its initial public offering.
1. Class: A shares
2. Stock code: 002675
3. Stock abbreviation: Dongcheng Biochemicals
4. Issuing volume: 27.000000 million shares
5. Par value: CNY1.00 per share
6. Issuing mechanism: a book building process will be conducted with a combination of online public offering and offline placement.
7. Targeted listing bourse: Shenzhen Stock Exchange
8. Offline placement volume: 13.500000 million shares
9. Online offering volume: 13.500000 million shares
10. Price: CNY26.00 per share
11. Offline subscription period: 15 May 2012
12. Online subscription date: 15 May 2012.
Date: 2012-05-04
Title: IPO
Yantai Dongcheng Biochemicals Co.,Ltd. has been approved by the China Securities Regulatory Commission (the CSCR) to issue 27.0000 million A-shares in its initial public offering, which is structured as follows:
1.Class: A shares
2.Size: 27.0000 million shares
3.Par value: CNY1.00 per share
4.Issuing mechanism: a book building process will be conducted with a combination of online public offering and offline placement.
5.Targeted listing bourse: Shenzhen Stock Exchange
6.Offline placement volume: 13.5000 million shares
7.Online offering volume:13.5000 million shares
8.IPO price inquiry period: from 07 May 2012 to 10 May 2012
9.IPO price determined: 14 May 2012
10.Offline subscription date:15 May 2012
11.Online subscription date: 15 May 2012
12.Expected listing date:N/A.